-
Je něco špatně v tomto záznamu ?
A Placebo-controlled double-blinded test of the biodiversity hypothesis of immune-mediated diseases: Environmental microbial diversity elicits changes in cytokines and increase in T regulatory cells in young children
MI. Roslund, A. Parajuli, N. Hui, R. Puhakka, M. Grönroos, L. Soininen, N. Nurminen, S. Oikarinen, O. Cinek, L. Kramná, AM. Schroderus, OH. Laitinen, T. Kinnunen, H. Hyöty, A. Sinkkonen, ADELE research group
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, randomizované kontrolované studie
- MeSH
- Bacteria genetika MeSH
- biodiverzita MeSH
- cytokiny MeSH
- dvojitá slepá metoda MeSH
- interleukin-10 * MeSH
- interleukin-17 * MeSH
- lidé MeSH
- písek MeSH
- předškolní dítě MeSH
- regulační T-lymfocyty MeSH
- Check Tag
- lidé MeSH
- předškolní dítě MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: According to the biodiversity hypothesis of immune-mediated diseases, lack of microbiological diversity in the everyday living environment is a core reason for dysregulation of immune tolerance and - eventually - the epidemic of immune-mediated diseases in western urban populations. Despite years of intense research, the hypothesis was never tested in a double-blinded and placebo-controlled intervention trial. OBJECTIVE: We aimed to perform the first placebo-controlled double-blinded test that investigates the effect of biodiversity on immune tolerance. METHODS: In the intervention group, children aged 3-5 years were exposed to playground sand enriched with microbially diverse soil, or in the placebo group, visually similar, but microbially poor sand colored with peat (13 participants per treatment group). Children played twice a day for 20 min in the sandbox for 14 days. Sand, skin and gut bacterial, and blood samples were taken at baseline and after 14 days. Bacterial changes were followed for 28 days. Sand, skin and gut metagenome was determined by high throughput sequencing of bacterial 16 S rRNA gene. Cytokines were measured from plasma and the frequency of blood regulatory T cells was defined as a percentage of total CD3 +CD4 + T cells. RESULTS: Bacterial richness (P < 0.001) and diversity (P < 0.05) were higher in the intervention than placebo sand. Skin bacterial community, including Gammaproteobacteria, shifted only in the intervention treatment to resemble the bacterial community in the enriched sand (P < 0.01). Mean change in plasma interleukin-10 (IL-10) concentration and IL-10 to IL-17A ratio supported immunoregulation in the intervention treatment compared to the placebo treatment (P = 0.02). IL-10 levels (P = 0.001) and IL-10 to IL-17A ratio (P = 0.02) were associated with Gammaproteobacterial community on the skin. The change in Treg frequencies was associated with the relative abundance of skin Thermoactinomycetaceae 1 (P = 0.002) and unclassified Alphaproteobacteria (P < 0.001). After 28 days, skin bacterial community still differed in the intervention treatment compared to baseline (P < 0.02). CONCLUSIONS: This is the first double-blinded placebo-controlled study to show that daily exposure to microbial biodiversity is associated with immune modulation in humans. The findings support the biodiversity hypothesis of immune-mediated diseases. We conclude that environmental microbiota may contribute to child health, and that adding microbiological diversity to everyday living environment may support immunoregulation.
Eastern Finland Laboratory Centre Kuopio Finland
Fimlab Laboratories Pirkanmaa Hospital District Tampere Finland
Natural Resources Institute Finland Helsinki and Turku Finland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024551
- 003
- CZ-PrNML
- 005
- 20221031100437.0
- 007
- ta
- 008
- 221017s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ecoenv.2022.113900 $2 doi
- 035 __
- $a (PubMed)35930838
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Roslund, Marja I $u Natural Resources Institute Finland (Luke), Helsinki and Turku, Finland; Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Niemenkatu 73, FI-15140 Lahti, Finland
- 245 12
- $a A Placebo-controlled double-blinded test of the biodiversity hypothesis of immune-mediated diseases: Environmental microbial diversity elicits changes in cytokines and increase in T regulatory cells in young children / $c MI. Roslund, A. Parajuli, N. Hui, R. Puhakka, M. Grönroos, L. Soininen, N. Nurminen, S. Oikarinen, O. Cinek, L. Kramná, AM. Schroderus, OH. Laitinen, T. Kinnunen, H. Hyöty, A. Sinkkonen, ADELE research group
- 520 9_
- $a BACKGROUND: According to the biodiversity hypothesis of immune-mediated diseases, lack of microbiological diversity in the everyday living environment is a core reason for dysregulation of immune tolerance and - eventually - the epidemic of immune-mediated diseases in western urban populations. Despite years of intense research, the hypothesis was never tested in a double-blinded and placebo-controlled intervention trial. OBJECTIVE: We aimed to perform the first placebo-controlled double-blinded test that investigates the effect of biodiversity on immune tolerance. METHODS: In the intervention group, children aged 3-5 years were exposed to playground sand enriched with microbially diverse soil, or in the placebo group, visually similar, but microbially poor sand colored with peat (13 participants per treatment group). Children played twice a day for 20 min in the sandbox for 14 days. Sand, skin and gut bacterial, and blood samples were taken at baseline and after 14 days. Bacterial changes were followed for 28 days. Sand, skin and gut metagenome was determined by high throughput sequencing of bacterial 16 S rRNA gene. Cytokines were measured from plasma and the frequency of blood regulatory T cells was defined as a percentage of total CD3 +CD4 + T cells. RESULTS: Bacterial richness (P < 0.001) and diversity (P < 0.05) were higher in the intervention than placebo sand. Skin bacterial community, including Gammaproteobacteria, shifted only in the intervention treatment to resemble the bacterial community in the enriched sand (P < 0.01). Mean change in plasma interleukin-10 (IL-10) concentration and IL-10 to IL-17A ratio supported immunoregulation in the intervention treatment compared to the placebo treatment (P = 0.02). IL-10 levels (P = 0.001) and IL-10 to IL-17A ratio (P = 0.02) were associated with Gammaproteobacterial community on the skin. The change in Treg frequencies was associated with the relative abundance of skin Thermoactinomycetaceae 1 (P = 0.002) and unclassified Alphaproteobacteria (P < 0.001). After 28 days, skin bacterial community still differed in the intervention treatment compared to baseline (P < 0.02). CONCLUSIONS: This is the first double-blinded placebo-controlled study to show that daily exposure to microbial biodiversity is associated with immune modulation in humans. The findings support the biodiversity hypothesis of immune-mediated diseases. We conclude that environmental microbiota may contribute to child health, and that adding microbiological diversity to everyday living environment may support immunoregulation.
- 650 _2
- $a Bacteria $x genetika $7 D001419
- 650 _2
- $a biodiverzita $7 D044822
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a cytokiny $7 D016207
- 650 _2
- $a dvojitá slepá metoda $7 D004311
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a interleukin-10 $7 D016753
- 650 12
- $a interleukin-17 $7 D020381
- 650 _2
- $a písek $7 D000080463
- 650 _2
- $a regulační T-lymfocyty $7 D050378
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Parajuli, Anirudra $u Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Niemenkatu 73, FI-15140 Lahti, Finland
- 700 1_
- $a Hui, Nan $u Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Niemenkatu 73, FI-15140 Lahti, Finland
- 700 1_
- $a Puhakka, Riikka $u Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Niemenkatu 73, FI-15140 Lahti, Finland
- 700 1_
- $a Grönroos, Mira $u Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Niemenkatu 73, FI-15140 Lahti, Finland
- 700 1_
- $a Soininen, Laura $u Ecosystems and Environment Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Niemenkatu 73, FI-15140 Lahti, Finland
- 700 1_
- $a Nurminen, Noora $u Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland
- 700 1_
- $a Oikarinen, Sami $u Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland
- 700 1_
- $a Cinek, Ondřej $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University, V Úvalu 84, Praha 5, 150 06 Prague, Czech Republic
- 700 1_
- $a Kramná, Lenka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University, V Úvalu 84, Praha 5, 150 06 Prague, Czech Republic
- 700 1_
- $a Schroderus, Anna-Mari $u Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland
- 700 1_
- $a Laitinen, Olli H $u Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland
- 700 1_
- $a Kinnunen, Tuure $u Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Eastern Finland Laboratory Centre (ISLAB), Kuopio, Finland
- 700 1_
- $a Hyöty, Heikki $u Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland; Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland
- 700 1_
- $a Sinkkonen, Aki $u Natural Resources Institute Finland (Luke), Helsinki and Turku, Finland. Electronic address: aki.sinkkonen@luke.fi
- 710 2_
- $a ADELE research group
- 773 0_
- $w MED00001478 $t Ecotoxicology and environmental safety $x 1090-2414 $g Roč. 242, č. - (2022), s. 113900
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35930838 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100435 $b ABA008
- 999 __
- $a ok $b bmc $g 1854332 $s 1175841
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 242 $c - $d 113900 $e 20220803 $i 1090-2414 $m Ecotoxicology and environmental safety $n Ecotoxicol Environ Safety $x MED00001478
- LZP __
- $a Pubmed-20221017